Literature DB >> 12934648

Detection and characterization of 45 kDa platelet activating factor acetylhydrolase in cerebrospinal fluid of children with meningitis.

Tae Chul Moon1, Mi Suk Kim, Su Jeong Lee, Tae Yoon Lee, Soon Hak Kwon, Suk Hwan Baek, Hyeun Wook Chang.   

Abstract

Platelet activating factor acetylhydrolase (PAF-AH) activity has been identified in cerebrospinal fluid (CSF) samples taken from children with meningitis. We reported that PAF-AH activity is significantly increased, by about 3 fold, in patients with meningitis compared to control subjects. Because of limited knowledge about this enzyme in CSF, we examined the biochemical properties of CSF PAF-AH. PAF-AH of CSF was calcium independent, showed a broad pH spectrum and was relatively heat stable. In addition, this enzyme activity was strongly inhibited by phenylmethanesulfonyl fluoride (PMSF), partially inhibited by p-bromophenacylbromide (p-BPB), uninhibited by iodoacetamide, and moderately stimulated by dithiothreitol (DTT). PAF-AH of CSF did not degrade phospholipid with a long chain fatty acyl group at sn-2 position. This enzyme hydrolyzed PAF and oxidatively modified phosphatidylcholine. Furthermore, we identified a monomeric polypeptide with a molecular weight of approximately 45 kDa by Western blot using human plasma PAF-AH antibody. These results suggested that plasma type PAF-AH activity exist in CSF taken from children with meningitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934648     DOI: 10.1007/bf02976880

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers
.

Authors:  Kai Wu; Jianfeng Xu; Regan Fong; Xiaozhou Yao; Yanmei Xu; William Guiney; Frank Gray; Andrew Lockhart
Journal:  Int J Clin Pharmacol Ther       Date:  2016-12       Impact factor: 1.366

2.  Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects.

Authors:  Mickael Huiban; Christopher Coello; Kai Wu; Yanmei Xu; Yvonne Lewis; Andrew P Brown; Mauro Buraglio; Chenbing Guan; Shaila Shabbir; Regan Fong; Jan Passchier; Eugenii A Rabiner; Andrew Lockhart
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

3.  Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage.

Authors:  Junwei Yang; Yixuan Zhang; Jing Xu; Yan Geng; Xiaoying Chen; Hongliang Yang; Shengnian Wang; Hengan Wang; Xucheng Jiang; Xiaokui Guo; Guoping Zhao
Journal:  PLoS One       Date:  2009-01-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.